Financial insights of SGRY

MyFinsight

For the quarter ending 2025-09-30, SGRY made $821,500K in revenue. -$22,700K in net income. Net profit margin of -2.76%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenues	821,500	826,200	776,000	770,400
Salaries and benefits	242,800	235,200	238,600	228,400
Supplies	208,900	215,000	215,800	201,400
Professional and medical fees	104,000	102,100	95,300	91,000
Lease expense	21,500	22,900	20,800	23,900
Other operating expenses	49,000	55,400	43,600	48,200
Cost of revenues	626,200	630,600	614,100	592,900
General and administrative expenses	22,400	36,100	36,000	29,200
Depreciation and amortization	39,500	40,300	36,300	50,200
Transaction and integration costs	12,600	18,100	24,700	29,400
Net loss on disposals, consolidations and deconsolidations	-15,600	3,000	-6,400	-14,700
Equity in earnings of unconsolidated affiliates	5,200	5,500	5,600	5,200
Litigation settlements	-5,100	0	-2,200	-500
Loss on debt extinguishment	-1,300	0	-	0
Other income, net	-1,700	-2,100	0	-2,200
Total operating expenses	715,800	714,500	714,100	709,500
Operating income	105,700	111,700	61,900	60,900
Interest expense, net	-74,900	-67,900	-62,200	-50,000
Income before income taxes	30,800	43,800	-300	10,900
Income tax expense	5,500	-1,100	0	4,500
Net income	25,300	44,900	-300	6,400
Less net income attributable to non-controlling interests	48,000	47,400	37,400	38,100
Net loss attributable to surgery partners, inc	-22,700	-2,500	-37,700	-31,700

Basic (in usd per share)	-0.18	-0.02	-0.3	-0.25
Basic (shares)	127,206,000	126,980,000	126,602,000	126,172,000
Diluted (in usd per share)	-0.18	-0.02	-0.3	-0.25
Diluted (shares)	127,206,000	126,980,000	126,602,000	126,172,000